<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02407782</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2011/16</org_study_id>
    <nct_id>NCT02407782</nct_id>
  </id_info>
  <brief_title>Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children</brief_title>
  <acronym>SCRATCH</acronym>
  <official_title>Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children: a Cluster Multicenter Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Scabies remains a frequent condition that affects adults and children. The aim of this study
      is to compare the efficacy and safety of two drug treatments against scabies in children and
      their close contacts. One group will apply topical permethrin 5% and the other group will
      receive oral ivermectin.

      Both groups will be treated twice, once at inclusion and the second time 10 days later. Both
      treatment regimens have been used widely and are safe to use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scabies is a common condition, even in European countries, and the annual incidence seems to
      have increased over the past several years.

      Children and infants represent one-third of patients with scabies. Diagnostic features
      comprise pruritus, skin burrows and the delta jet wing dermoscopic sign.

      In many countries, topical permethrin is the first line therapy. Moreover, oral treatment
      with ivermectin represents an interesting alternative therapy, usually used as one dose of
      200μg/kg, and more and more frequently recommended as two doses (one on day 1 and one between
      day 8 and day 15) without strong evidence. Management of scabies requires giving a treatment
      not only to the patient but also to the patient's close contacts.

      The objective of our study is to compare efficacy and safety of topical permethrin applied
      twice at day 1 and day 10 versus oral ivermectin given twice at day 1 and day 10 to treat
      scabies in children and their close contacts. Children (2 to15 years) with scabies and their
      close contacts - or first circle- will be randomized 1:1 to receive permethrin or ivermectin.

      A clinical follow-up will be performed 28 days (V2) and 56 days (V3) after the inclusion,
      including a dermatological examination and to collect safety data.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of skin lesions and healing at day 28</measure>
    <time_frame>Day 28</time_frame>
    <description>Healing of skin lesions and disappearance of pruritus at day 28 of the treatment in the cluster composed by the child and its close contacts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of skin lesions and healing at day 56</measure>
    <time_frame>day 56</time_frame>
    <description>Healing of skin lesions and disappearance of pruritus at day 56 of the treatment in the cluster composed by the child and its close contacts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of skin lesions and healing at day 28 and 56 in children</measure>
    <time_frame>Day 28 and Day 56</time_frame>
    <description>Healing of skin lesions and disappearance of pruritus at day 28 and day 56 of the treatment in children</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of unaffected members in clusters treated by permethrin versus ivermectin at D0, D28 and D56.</measure>
    <time_frame>day 0, day 28 and d56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of delta wing jet sign(s) and mite egs</measure>
    <time_frame>Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of serious adverse events</measure>
    <time_frame>Day 56</time_frame>
    <description>Safety in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adherence of patients</measure>
    <time_frame>Day 56</time_frame>
    <description>Preference and adherence of patients in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">502</enrollment>
  <condition>Scabies</condition>
  <arm_group>
    <arm_group_label>Ivermectin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Permethrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivermectin</intervention_name>
    <description>oral ivermectin, 200μg/kg given at baseline and at day 10.</description>
    <arm_group_label>Ivermectin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Permethrin</intervention_name>
    <description>topical permethrin 5% cream applied at baseline and at day 10.</description>
    <arm_group_label>Permethrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age less than 16 years

          -  Weight more than 15 kg

          -  Documented diagnosis of scabies, defined by positive dermoscopic examination.

        Exclusion Criteria:

          -  Previous scabies therapy during the past 4 weeks

          -  Known allergy to ivermectin or permethrin

          -  Widespread eczematization or impetiginization

          -  Liver or renal failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruneau Giraudeau, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Centre d'investigation clinique Inserm 1415 CHRU de Tours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Franck BORALEVI, Professor</last_name>
    <phone>05 56 79 59 41</phone>
    <email>franck.boralevi@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabienne NACKA, PhD</last_name>
    <phone>05 57 82 01 08</phone>
    <email>fabienne.nacka@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Bordeaux Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <state>Aquitaine</state>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franck BORALEVI, Professor</last_name>
      <phone>05 56 79 59 41</phone>
      <email>franck.boralevi@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Fabienne NACKA, PhD</last_name>
      <phone>05 57 82 01 08</phone>
      <email>fabienne.nacka@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Christine Léauté-Labrèze, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Fontès-Plantade, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHG de Chalon sur Saône</name>
      <address>
        <city>Chalon sur Saône</city>
        <state>Bourgogne</state>
        <zip>71321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Groujon, Doctor</last_name>
      <phone>03 85 91 00 53</phone>
      <email>Elisa.Goujon@ch-chalon71.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Friedel, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille Leleu, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Journet, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <state>Bourgogne</state>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Vabres, Professor</last_name>
      <phone>03 80 29 33 36</phone>
      <email>pierre.vabres@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Bertille Bonniaud, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Blandine Bel, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Géraldine Jeudy, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <state>Bretagne</state>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Dupuy, Professor</last_name>
      <phone>02 99 28 43 68</phone>
      <email>alain.dupuy@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Droitcourt, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henri Adamski, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Dinulescu, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours</name>
      <address>
        <city>Tours</city>
        <state>Centre-Val de Loire</state>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annabel Maruani, Professor</last_name>
      <phone>02 47 47 46 25</phone>
      <email>annabel.maruani@univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Marie Berton, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Paul Claudel, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole Dannepond, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriela Georgescou, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louise Lagier, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle Le Bire, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gérard Lorette, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Argenteuil</name>
      <address>
        <city>Argenteuil</city>
        <state>Ile de France</state>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Mahé, Doctor</last_name>
      <phone>01 34 23 28 99</phone>
      <email>emmanuel.mahe@apr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Maud Amy de la Bretèque, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michèle Sigal, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole Sin, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Bilan, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Créteil - Hôpital Henry Mondor</name>
      <address>
        <city>Créteil</city>
        <state>Ile de France</state>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Chosidow, Professor</last_name>
      <phone>01 49 81 25 01</phone>
      <email>olivier.chosidow@hmn.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Giao Do Pham, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amandine Servy, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saskia Oro, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HP - Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <state>Ile de France</state>
        <zip>75935</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle Bourrat, Doctor</last_name>
      <phone>01 40 09 41 39</phone>
      <email>emmanuelle.bourrat@rdb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Ulrich Meinzer, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <state>Languedoc-Roussillon</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Bessis, Doctor</last_name>
      <phone>04 67 33 69 59</phone>
      <email>d-bessis@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Charlotte Pernet, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de la Réunion</name>
      <address>
        <city>Saint-Pierre</city>
        <state>Martinique</state>
        <zip>97448</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette Miquel, Doctor</last_name>
      <phone>0262359000</phone>
      <email>miquel.juliette@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>Aude Fischer, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Guinaud, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <state>Pays de La Loire</state>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludovic Martin, Professor</last_name>
      <phone>06 65 81 12 95</phone>
      <email>LuMartin@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Martine Avenel-Audran, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yannick Le Corre, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Elodie Sarre, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH du Mans</name>
      <address>
        <city>Le Mans</city>
        <state>Pays de la Loire</state>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Beneton, Doctor</last_name>
      <phone>02 43 43 43 58</phone>
      <email>nbeneton@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Corina Bara, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé Maillard, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Lecouflet, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <state>Pays de la Loire</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien Barbarot, Doctor</last_name>
      <phone>02 40 08 40 86</phone>
      <email>sebastien.barbarot@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Hélène Aubert-Wastiaux, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Bernier, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI de Fréjus</name>
      <address>
        <city>Fréjus</city>
        <state>Provence-Alpes-Côte d'Azur</state>
        <zip>83600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Hubiche, Doctor</last_name>
      <phone>04 94 40 25 46</phone>
      <email>hubiche-t@chi-frejus-saint-raphael.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal Del Giudice, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <state>Provence-Alpes-Côte-d'Azur</state>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Chiaverini, Doctor</last_name>
      <phone>04 92 03 92 11</phone>
      <email>chiaverini.c@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal Delaunay, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Lyon</name>
      <address>
        <city>Bron</city>
        <state>Rhône-Alpes</state>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Phan, Doctor</last_name>
      <phone>04 27 85 61 26</phone>
      <email>alice.phan@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Mona Amini-Adle, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Dalle, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Poulahon, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2015</study_first_submitted>
  <study_first_submitted_qc>March 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2015</study_first_posted>
  <last_update_submitted>June 3, 2016</last_update_submitted>
  <last_update_submitted_qc>June 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scabies</keyword>
  <keyword>children</keyword>
  <keyword>cluster</keyword>
  <keyword>permethrin</keyword>
  <keyword>Ivermectin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scabies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ivermectin</mesh_term>
    <mesh_term>Permethrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

